NO20023737L - Methods and Preparations for the Treatment of Inflammatory Disorder - Google Patents

Methods and Preparations for the Treatment of Inflammatory Disorder

Info

Publication number
NO20023737L
NO20023737L NO20023737A NO20023737A NO20023737L NO 20023737 L NO20023737 L NO 20023737L NO 20023737 A NO20023737 A NO 20023737A NO 20023737 A NO20023737 A NO 20023737A NO 20023737 L NO20023737 L NO 20023737L
Authority
NO
Norway
Prior art keywords
preparations
treatment
methods
inflammatory disorder
disorder
Prior art date
Application number
NO20023737A
Other languages
Norwegian (no)
Other versions
NO20023737D0 (en
Inventor
Elizabeth Keating
James M Kanagy
Original Assignee
Smithkline Beecham Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Co filed Critical Smithkline Beecham Co
Publication of NO20023737D0 publication Critical patent/NO20023737D0/en
Publication of NO20023737L publication Critical patent/NO20023737L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
NO20023737A 2000-02-08 2002-08-07 Methods and Preparations for the Treatment of Inflammatory Disorder NO20023737L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18087900P 2000-02-08 2000-02-08
PCT/US2001/003972 WO2001058441A1 (en) 2000-02-08 2001-02-08 Method and compositions for treating an inflammatory disease

Publications (2)

Publication Number Publication Date
NO20023737D0 NO20023737D0 (en) 2002-08-07
NO20023737L true NO20023737L (en) 2002-09-27

Family

ID=22662062

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023737A NO20023737L (en) 2000-02-08 2002-08-07 Methods and Preparations for the Treatment of Inflammatory Disorder

Country Status (16)

Country Link
EP (1) EP1253919A4 (en)
JP (1) JP2003522142A (en)
KR (1) KR20020073577A (en)
CN (1) CN1398181A (en)
AU (1) AU7205701A (en)
BR (1) BR0108087A (en)
CA (1) CA2398184A1 (en)
CZ (1) CZ20022682A3 (en)
HK (1) HK1051319A1 (en)
HU (1) HUP0300689A3 (en)
IL (1) IL150963A0 (en)
MX (1) MXPA02007688A (en)
NO (1) NO20023737L (en)
PL (1) PL356447A1 (en)
WO (1) WO2001058441A1 (en)
ZA (1) ZA200206252B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7338971B2 (en) 2001-08-30 2008-03-04 El-Naggar Mawaheb M Treatment of inflammatory, cancer, and thrombosis disorders
NZ532278A (en) * 2001-09-19 2006-02-24 Altana Pharma Ag Combination of a PDE inhibitor and an NSAID
HUP0401984A3 (en) * 2001-10-31 2005-06-28 Merck Patent Gmbh Use of type 4 phosphodiesterase inhibitors for preparation of pharmaceutical compositions and combination with other active ingredients
WO2004098605A1 (en) * 2003-05-12 2004-11-18 Altana Pharma Ag Pharmaceutical composition comprising a pde4 inhibitor and il-1 trap
WO2005020926A2 (en) * 2003-08-28 2005-03-10 Pharmacia Corporation Treatment or prevention of vascular disorders with cox-2 inhibitors in combination with cyclic amp-specific phosphodiesterase inhibitors
EP2400961B1 (en) * 2009-02-27 2017-11-22 Boehringer Ingelheim International GmbH Medicine combinations containing pde4 inhibitors and nsaids
CA2753604A1 (en) * 2009-02-27 2010-09-02 Boehringer Ingelheim International Gmbh Drug combinations containing pde4-inhibitors and nsaids
PL2593452T3 (en) 2010-07-14 2017-07-31 Novartis Ag Ip receptor agonist heterocyclic compounds
TW201335160A (en) 2012-01-13 2013-09-01 Novartis Ag IP receptor agonist heterocyclic compounds
WO2014125413A1 (en) 2013-02-13 2014-08-21 Novartis Ag Ip receptor agonist heterocyclic compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4061779A (en) * 1973-09-11 1977-12-06 Beecham Group Limited Naphthalene derivatives having anti-inflammatory activity
GB9108128D0 (en) * 1991-04-15 1991-06-05 Zambeletti Spa L Novel formulation
MX9301943A (en) * 1992-04-02 1994-08-31 Smithkline Beecham Corp COMPOUNDS.
US6005118A (en) * 1996-05-03 1999-12-21 Caron; Stephane Methods of preparing 4-cyano-4 (substituted indazole) cyclohexane-carboxylic acids useful as PDE4 inhibitors
FR2753706B1 (en) * 1996-09-20 1998-10-30 NOVEL N-SUBSTITUTED CYCLIC AMINES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
PL356447A1 (en) 2004-06-28
CA2398184A1 (en) 2001-08-16
EP1253919A4 (en) 2007-03-14
HUP0300689A2 (en) 2003-07-28
MXPA02007688A (en) 2002-12-13
BR0108087A (en) 2002-10-29
EP1253919A1 (en) 2002-11-06
CN1398181A (en) 2003-02-19
CZ20022682A3 (en) 2003-09-17
NO20023737D0 (en) 2002-08-07
AU7205701A (en) 2001-08-20
KR20020073577A (en) 2002-09-27
HUP0300689A3 (en) 2003-09-29
IL150963A0 (en) 2003-02-12
JP2003522142A (en) 2003-07-22
HK1051319A1 (en) 2003-08-01
ZA200206252B (en) 2003-08-26
WO2001058441A1 (en) 2001-08-16

Similar Documents

Publication Publication Date Title
NO994778L (en) Methods and Preparations for the Treatment of Inflammatory Bowel Syndrome
NO20004098D0 (en) Methods and preparations for the treatment of macrophage-mediated disorders
NO20011964D0 (en) Well treatment fluids and methods using them
NO20033387L (en) Modified antibodies and methods of use
NO20014560D0 (en) Quinasolines and their therapeutic use
NO20024610L (en) Synergistic methods and compositions for the treatment of cancer
NO20030397D0 (en) Amyloid targeting imaging agents and uses of the same
NO994613D0 (en) Procedures and preparations for the treatment of sleep apnea
NO20015542D0 (en) Process for the preparation and use of N-desmethylzopiclones
NO20014314L (en) Compositions and methods for the treatment of staphylococcal infection
NO20033854L (en) N-but-3-enyl-norbuprenorphine and methods of use
NO20015516D0 (en) Preparations and uses of ET743 for the treatment of cancer
NO20012963D0 (en) Process for the preparation of 3-alkanoylindoles and 3-alkylindoles
NO20041214L (en) Substituted benzimidazole compounds and their use in the treatment of cancer
IS6966A (en) Cyano-linked dihydropyrimidine compounds and their use in the treatment of diseases
NO20014648L (en) Compounds and methods for the treatment of asthma, allergies and inflammatory diseases
DK1381382T3 (en) Methods and Preparations for the Treatment of Eye Diseases
NO20015772L (en) Compounds and methods for the treatment of post-traumatic stress syndrome
NO20033506D0 (en) Parasite-killing preparations and methods of use
NO20023737L (en) Methods and Preparations for the Treatment of Inflammatory Disorder
NO20010464L (en) Methods and Preparations for the Treatment of Gastroesophageal Reflux Syndrome
NO20023678L (en) Treatment of allergic and inflammatory conditions
DK1667693T3 (en) Preparations and Methods for the Use of Lamellar Bodies for Therapeutic Purposes
PL366009A1 (en) Methods and compositions for the treatment of inflammatory diseases
PT1178981E (en) SUBSTITUTED 3-PYRIDYL-4-ARYLIPYROLS AND THERAPEUTIC AND PROFILACTIC METHODS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application